Delivery Order SPE2DB20D2014-SPE2DB25FC94U
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,825.26 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on August 13, 2025, with completion scheduled for August 14, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,360.45 for Mounjaro 15 mg/0.5 ml pen injectors on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $3,265.08 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injections on August 8, 2025, with completion targeted for August 11, 2025. This non-competitive, firm fixed-price delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a $2,029.53 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. The contract carries no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a $6,045.27 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's established portfolio of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,476.27 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injections (0.5 mL), with an ultimate completion date of September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $17,489.37 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injections. This non-set-aside, firm fixed-price delivery order was competitively awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,758.57 firm fixed-price delivery order on August 14, 2025, for Mounjaro 2.5 mg/0.5 mL pen injections, with an ultimate completion date of August 15, 2025. The contract, issued without set-aside designation, represents a competitively awarded procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $2,176.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injections on August 11, 2025, with completion targeted for August 12, 2025. This non-competitive, non-set-aside order is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC94UDelivery Order
The Defense Logistics Agency awarded a $6,638.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on September 8, 2025, with completion scheduled for September 9, 2025. This non-competitive delivery order represents a single pharmaceutical supply transaction executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle valued through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its prime IDC with DLA to supply medications across multiple therapeutic domains to support military and federal healthcare systems. Mounjaro, a diabetes medication, aligns with AmerisourceBergen's existing portfolio of specialty pharmaceutical products distributed to the Defense Health Agency and other government healthcare customers. As a child order under the larger SPE2DX contract vehicle, this delivery order demonstrates the company's role as a critical vendor in the federal medical supply chain, fulfilling routine pharmaceutical replenishment needs for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 9/8/25 |